Author

A.-K. Pedersen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

J. V. Olsen· 3 shared A. N. Matralis· 1 shared B. C. Searle· 1 shared C. Tzaferis· 1 shared D. Damozay· 1 shared D. Papadopoulou· 1 shared E. Christodoulou-Vafeiadou· 1 shared E. Krismer· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

J. V. Olsen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway and dependent on low IGF1R level

S. H. Joergensen, K. B. Emdal, A.-K. Pedersen, L. N. Axelsen, H. F. Kildegaard, D. Damozay, T. A. Pedersen, M. Groenborg, R. Slaaby, P. K. Nielsen, J. V. Olsen

The paper uses multi-layered proteomics to show insulin increases EphA2 via ERK pathway, independent of insulin resistance, and dependent on low IGF1R levels.

bioRxiv · Dec 14, 2023 · PreprintCell Biology

Optimizing linear ion trap data independent acquisition towards single cell proteomics

T. Phlairaharn, Z. Ye, E. Krismer, A.-K. Pedersen, M. Pietzner, J. V. Olsen, E. M. Schoof, B. C. Searle

This study optimizes linear ion trap data independent acquisition for single-cell proteomics, showing quantitative accuracy down to 0.5 ng on column using LIT-based libraries from as few as 40 cells.

bioRxiv · Feb 21, 2023Biochemistry

Repurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis.

D. Papadopoulou, F. Roumelioti, C. Tzaferis, P. Chouvardas, A.-K. Pedersen, F. Charalampous, E. Christodoulou-Vafeiadou, L. Ntari, N. Karagianni, M. Denis, J. V. Olsen, A. N. Matralis, G. Kollias

This study identifies Amisulpride as a potential therapeutic for arthritis by reducing synovial fibroblast activation, independent of its known targets.

bioRxiv · Aug 2, 2022 · PreprintPharmacology & Toxicology